Table 1 The clinical characteristics of the included patients in both the training and validation cohort
Characteristics | Training (n = 130) | Validation (n = 56) | P-value |
|---|---|---|---|
Age, years (mean ± SD) | 47.6 ± 13.4 | 47.8 ± 12.9 | 0.904 |
CA125 (mean, range) | 552 (5–5000) | 526 (10–5000) | 0.295 |
Ki67 (mean ± SD) | 28.22 ± 24.09 | 27.50 ± 22.80 | 0.467 |
FIGO (%) | |||
1 | 63 (48) | 22 (39) | 0.553 |
2 | 10 (8) | 6 (11) | |
3 | 52 (40) | 24 (43) | |
4 | 5 (4) | 4 (7) | |